SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001731122-22-000703
Filing Date
2022-04-11
Accepted
2022-04-11 17:08:47
Documents
3
Period of Report
2022-04-11

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A e3687_def14a.htm DEF 14A 598863
2 GRAPHIC img_001.jpg GRAPHIC 306565
3 GRAPHIC img_002.jpg GRAPHIC 313006
  Complete submission text file 0001731122-22-000703.txt   1453441
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

IRS No.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 001-37606 | Film No.: 22820328
SIC: 2836 Biological Products, (No Diagnostic Substances)